纳指生物科技ETF(513290)
动态评分： 5.70分
投资组合
| 报告日期 | 代码 | 名称 | 类型 | 金额(万元) | 占期初比 |
| 2023-12-31 | ASND | Ascendis Pharma AS ADR | 买入 | 527.46 | 7% |
| 2023-12-31 | ITCI | Intra-Cellular Therapies Inc | 买入 | 498.34 | 6.61% |
| 2023-12-31 | BBIO | BridgeBio Pharma Inc | 买入 | 487.02 | 6.46% |
| 2023-12-31 | PCVX | Vaxcyte Inc | 买入 | 441.06 | 5.85% |
| 2023-12-31 | IMVT | Immunovant Inc | 买入 | 429.27 | 5.7% |
| 2023-12-31 | HALO | 奥洛兹美医疗 | 买入 | 418.61 | 5.56% |
| 2023-12-31 | LEGN | Legend Biotech Corp ADR | 买入 | 412.77 | 5.48% |
| 2023-12-31 | CRSP | CRISPR Therapeutics AG | 买入 | 393.76 | 5.23% |
| 2023-12-31 | HZNP | Horizon Therapeutics plc | 买入 | 391.89 | 5.2% |
| 2023-12-31 | BPMC | Blueprint Medicines Corp | 买入 | 376.39 | 5% |
| 2023-12-31 | RVMD | Revolution Medicines Inc | 买入 | 375.21 | 4.98% |
| 2023-12-31 | ALKS | 阿尔凯默斯 | 买入 | 369.41 | 4.9% |
| 2023-12-31 | ACAD | 阿卡迪亚 | 买入 | 362.48 | 4.81% |
| 2023-12-31 | MDGL | Madrigal Pharmaceuticals Inc | 买入 | 355.15 | 4.71% |
| 2023-12-31 | CYTK | Cytokinetics Inc | 买入 | 338.71 | 4.5% |
| 2023-12-31 | MRTX | Mirati Therapeutics Inc | 买入 | 319.1 | 4.24% |
| 2023-12-31 | INSM | Insmed Inc | 买入 | 316.23 | 4.2% |
| 2023-12-31 | NUVL | Nuvalent Inc-A | 买入 | 306.59 | 4.07% |
| 2023-12-31 | FOLD | 爱美医疗 | 买入 | 302.96 | 4.02% |
| 2023-12-31 | RARE | Ultragenyx Pharmaceutical Inc | 买入 | 300.75 | 3.99% |
公告&资料
